Moskow Wyeth Prempro
Ury & Moskow and Bubalo Rotman secured a $4 million verdict plus punitive damages against Wyeth, Inc., on behalf of their client who developed breast cancer after taking Prempro.
A Connecticut jury found that Wyeth’s hormone-replacement drug Prempro was responsible for the Plaintiff’s invasive breast cancer and that Prempro is an unreasonably dangerous product. Wyeth must also pay punitive damages based on its handling of the drug, the jury concluded.
Prempro is a hormone therapy medication containing a combination of estrogens and progesterone that is prescribed to treat the symptoms of menopause, including hot flashes and mood swings. More than 6 million women took Prempro and similar drugs until a 2002 study by the National Institutes of Health revealed their link to cancer. Wyeth’s Prempro sales reached $2 billion before the release of the study.
Attorney Gregory Bubalo led the Prempro case in collaboration with Steven Rotman and Paula Bliss, all of the Bubalo Rotman firm of Louisville, Boston, and Lexington, and with Neal Moskow of Ury & Moskow, LLC. Moskow, who has represented plaintiffs Margaret and Joseph Fraser since 2004, said that he was pleased with the verdict, which came after three weeks of evidence. “The jury found that Wyeth failed to properly test for and warn about the risks of Prempro, and misrepresented what it did know. It is also gratifying that the jury – as we believed all along – found that such conduct was so reckless that it warranted an award of punitive damages. After eight years of fighting this giant pharmaceutical company, we are all so pleased that Maggie and Joe finally have some justice,” Moskow said.
The trial attorneys of Ury & Moskow, LLC are renown for excellent representation at all levels of the State and Federal courts in a broad range of legal matters related to business and civil litigation, in addition to personal injury lawsuits involving pharmaceuticals and medical devices. With offices in Fairfield, Connecticut and Washington, D.C., Ury & Moskow has a well-earned reputation for professional responsibility and a fierce commitment to successful resolution for every client.
For more information on this verdict please read:
- Jury awards $4M in first New England Prempro verdict – Mass High Tech News – 4/23/12
- $4 Million Awarded to Prempro Breast Cancer Survivor – Wall Street Journal – 4/23/12